Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Peptron's PT105, a sustained-release Leuprolide, established the bioequivalence with Takeda's Leuplin 2022-11-28 09:00
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC 2021-04-16 20:00
1